Clinical Epigenetics
Scope & Guideline
Bridging Science and Medicine: The Future of Epigenetics
Introduction
Aims and Scopes
- Epigenetic Mechanisms in Disease:
The journal covers various diseases where epigenetic modifications play a crucial role, including cancer, cardiovascular diseases, and autoimmune disorders. It emphasizes the exploration of how DNA methylation, histone modifications, and non-coding RNAs influence disease progression and prognosis. - Clinical Applications of Epigenetic Research:
Research published in the journal often focuses on the clinical implications of epigenetic findings, including the development of biomarkers for early disease detection, treatment responses, and personalized medicine approaches. - Methodological Advances in Epigenetics:
The journal highlights innovative methodologies in epigenetic research, including advanced techniques for DNA methylation analysis, epigenome-wide association studies (EWAS), and the integration of multi-omics data to enhance understanding of complex biological systems. - Environmental and Lifestyle Influences on Epigenetics:
There is a significant focus on how environmental factors, such as diet, pollution, and lifestyle choices, affect epigenetic modifications and their subsequent impact on health outcomes. - Intergenerational Epigenetic Effects:
The journal explores how epigenetic changes can be transmitted across generations, influencing the health and disease susceptibility of offspring, thereby linking maternal and paternal exposures to later-life health outcomes.
Trending and Emerging
- Epigenetics and Aging:
A significant trend is the exploration of epigenetic changes associated with aging and age-related diseases. Research focusing on epigenetic clocks and their predictive value for longevity and health outcomes is gaining momentum. - Cancer Epigenetics and Therapeutics:
The journal increasingly emphasizes the role of epigenetics in cancer biology, including the identification of epigenetic biomarkers for diagnosis and prognosis, as well as novel therapeutic strategies targeting epigenetic modifications. - Impact of Lifestyle and Environmental Factors:
There is a growing body of research investigating how lifestyle choices (such as diet, exercise, and smoking) and environmental exposures (pollution, chemicals) influence epigenetic modifications, linking these changes to chronic diseases. - Machine Learning and Epigenomics:
The integration of machine learning techniques to analyze complex epigenomic data sets is an emerging area of focus. This trend highlights the innovative use of computational methods to identify patterns and predict clinical outcomes based on epigenetic profiles. - Epigenetics in Mental Health:
Recent publications indicate a rising interest in the role of epigenetics in mental health disorders, including depression and anxiety, exploring how epigenetic modifications affect brain function and behavior.
Declining or Waning
- Basic Research on Epigenetic Mechanisms:
There appears to be a waning interest in purely basic research focused solely on the fundamental mechanisms of epigenetic regulation without direct clinical implications. The trend is moving towards studies that translate basic findings into clinical applications. - Single-Factor Studies:
Research that investigates the role of single epigenetic factors (such as individual genes or specific histone modifications) in isolation has become less prevalent. There is a growing preference for multi-factorial approaches that consider the interplay of various epigenetic and environmental influences. - Animal Models in Epigenetics:
Studies relying heavily on animal models to investigate epigenetic phenomena, particularly in the absence of human clinical relevance, have decreased. The focus is shifting towards human studies that provide direct insights into clinical applications. - Epigenetics in Rare Diseases:
Research related to the epigenetic aspects of rare diseases has seen a decline. The journal is increasingly prioritizing studies with broader implications and relevance to more common health conditions.
Similar Journals
CHROMOSOMA
Elevating Genetic Knowledge Through Rigorous ScholarshipCHROMOSOMA is a prestigious journal dedicated to advancing the field of genetics, published by Springer in Germany. With an ISSN of 0009-5915 and an E-ISSN of 1432-0886, this journal has been a cornerstone in the publishing landscape since its inception in 1939, serving as a critical resource for researchers and professionals interested in the intricacies of chromosomal biology. Although it operates on a subscription basis, the journal's rigorous peer-review process ensures the dissemination of high-quality research findings. With a commendable Q2 ranking in both genetic and clinical genetics categories as of 2023, CHROMOSOMA aims to bridge theoretical concepts with practical applications in medicine and biology. Researchers will appreciate its relevance, as indicated by its Scopus ranks and integration of diverse topics ranging from molecular genetics to clinical implications. By fostering collaboration and knowledge-sharing among scholars, CHROMOSOMA continues to shape the future of genetic research.
RNA
Connecting Discoveries in RNA BiologyRNA is a premier journal in the field of molecular biology, published by COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT. With an impressive impact factor reflected by its Q1 status in the Molecular Biology category, this journal has established itself as an essential resource for researchers and professionals dedicated to understanding the role of RNA in biological processes. Spanning over two decades of impactful research from 1995 to 2024, RNA covers a broad spectrum of topics, including RNA biology, gene regulation, and therapeutic innovations. Researchers can access its extensive array of original research articles, reviews, and commentary, making it a vital conduit for new discoveries and methodologies in the field. With its high ranking within Scopus at Rank #115/410 and a 72nd percentile ranking in the domain of Biochemistry, Genetics, and Molecular Biology, RNA continues to advance the understanding of RNA and its critical contributions to life sciences.
JOURNAL OF MOLECULAR MEDICINE-JMM
Exploring the Intersection of Biochemistry and Clinical Innovation.JOURNAL OF MOLECULAR MEDICINE (JMM) is a premier publication dedicated to advancing the field of molecular medicine, encompassing critical areas such as drug discovery, genetics, and biochemistry. Published by Springer Heidelberg in Germany, this influential journal has established its significance within the academic community, achieving an impressive Q1 ranking across multiple categories as of 2023, including Drug Discovery, Clinical Genetics, and Molecular Medicine. With a focus on publishing high-quality research and novel insights, JMM appeals to a diverse audience of researchers, professionals, and students passionate about the molecular underpinnings of health and disease. The journal, which has seen a convergence of relevant research spanning from 1976 to 2024, is instrumental in showcasing groundbreaking studies that push the boundaries of knowledge in molecular therapeutics and biomedical science. While it does not offer open access, the rigor of its peer-reviewed content ensures that each publication is a valuable addition to the scientific discourse surrounding molecular medicine. For comprehensive studies and reviews that highlight the intersection of molecular biology and clinical application, look no further than JOURNAL OF MOLECULAR MEDICINE.
AGING CELL
Illuminating the Pathways of Aging and HealthAGING CELL is a premier peer-reviewed journal published by Wiley, specializing in the rapidly evolving field of aging research and cell biology. Established in 2002 and enjoying an impressive track record as evidenced by its Q1 ranking in both Aging and Cell Biology categories for 2023, the journal has become a vital resource for researchers and professionals alike. With a significant impact factor highlighting its scholarly influence, AGING CELL offers an open access model since 2014, ensuring that groundbreaking research is accessible to the global community. The journal covers a wide array of topics related to the mechanisms of aging at the cellular and molecular levels, making it essential reading for anyone invested in understanding the complexities of aging processes and their implications for health and disease. With a broad international readership based in the United Kingdom and beyond, AGING CELL is dedicated to disseminating high-quality research that impacts scientific understanding and fosters advances in the field.
Aging-US
Bridging Science and Health in Aging StudiesAging-US is a premier peer-reviewed journal dedicated to advancing the field of aging research and cell biology. Published by IMPACT JOURNALS LLC, this journal serves as a vital resource for researchers and professionals exploring the biological mechanisms of aging and their implications for health and disease. With a commendable impact factor reflected in its 2023 Scopus rankings, where it stands at Rank #10/38 in the category of Aging and Rank #63/285 in Cell Biology, Aging-US exemplifies rigorous scientific excellence. Its open access policy enhances accessibility, fostering a wider dissemination of knowledge in both academic and clinical settings. Spanning from 2009 to 2024, the journal provides a platform for groundbreaking studies and innovative methodologies, ensuring that it remains at the forefront of the dynamic conversations surrounding aging and cellular biology. Engage with Aging-US to contribute to the evolving narratives of longevity and cellular health.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
Unveiling Insights in Neurological DisordersJOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, published by Oxford University Press Inc, stands as a pivotal resource for advancing research and knowledge in the domains of neuropathology and experimental neurology. Established in 1942, this esteemed journal has expanded its influence, as evidenced by its Q1 rankings in both Neurology (clinical) and Pathology and Forensic Medicine, along with its strong placement in Cellular and Molecular Neuroscience. With an emphasis on innovative research and clinical practices, it caters to a diverse audience, including researchers and clinicians dedicated to understanding neurological disorders through a multidisciplinary lens. While not open access, this journal provides access to cutting-edge studies that are pivotal in shaping the future of medical science and pathology. Researchers benefit from its rigorous peer-review process, ensuring the publication of high-caliber work that meets the evolving demands of the field.
CANCER SCIENCE
Pioneering discoveries in cancer biochemistry and genetics.Cancer Science, an esteemed journal published by Wiley, stands at the forefront of oncology research, boasting an impressive impact factor and a classification in the Q1 category for its contributions in Cancer Research, Medicine, and Oncology as of 2023. Since its inception in 2003 and transitioning to an Open Access model in 2014, the journal has facilitated global dissemination of critical research findings, ensuring that vital information remains accessible to researchers, clinicians, and students alike. With its comprehensive scope covering cutting-edge discoveries in cancer biochemistry, genetics, and molecular biology, Cancer Science is recognized for its rigorous peer-review process and significant contributions to advancing our understanding of cancer. The journal, located at 111 River St, Hoboken, NJ, is an essential resource for anyone dedicated to improving treatment outcomes and pushing the boundaries of cancer research.
Epigenetics
Bridging the Gap Between Genetics and DiseaseEpigenetics, published by Taylor & Francis Inc, is a leading journal in the fields of Cancer Research, Medicine (miscellaneous), and Molecular Biology. With an ISSN of 1559-2294 and an E-ISSN of 1559-2308, this journal has been paving the way for groundbreaking research since its inception in 2006, and it continues to play a crucial role in advancing our understanding of epigenetic mechanisms and their implications in health and disease. The journal is highly regarded, ranking in the Q1 category for Medicine and Q2 for both Cancer Research and Molecular Biology according to the 2023 category quartiles. Researchers and professionals in the field will find invaluable insights and innovative studies within its pages, making it an essential resource for those engaged in cutting-edge research. Although the journal is not open access, it encourages a comprehensive understanding through high-quality peer-reviewed content. With its creative exploration of the epigenetic landscape, Epigenetics serves as a vital platform for the sharing of knowledge that could lead to breakthroughs in treatments and therapies.
CELLULAR & MOLECULAR BIOLOGY LETTERS
Transforming Knowledge in Biochemistry and Cell BiologyCELLULAR & MOLECULAR BIOLOGY LETTERS, published by BMC, is a premier open-access journal dedicated to disseminating high-quality research in the fields of Biochemistry, Cell Biology, and Molecular Biology. Established in 1996, the journal has emerged as a leader in its domain, boasting an impressive Q1 ranking across three critical categories as of 2023, reflecting its significant impact within the scientific community. With an ISSN of 1425-8153 and an E-ISSN of 1689-1392, it offers accessible research findings to a global audience, having been open access since 2013. Situated in the United Kingdom, at CAMPUS, 4 CRINAN ST, LONDON N1 9XW, the journal continues to serve as a vital resource for researchers, professionals, and students, contributing to advancements in the understanding of cellular and molecular processes. By providing a platform for original research, reviews, and short communications, CELLULAR & MOLECULAR BIOLOGY LETTERS plays a crucial role in fostering dialogue and collaboration within the scientific community.
Genes and Environment
Navigating the Complexities of Genes and EnvironmentGenes and Environment is a premier interdisciplinary journal published by BMC that explores the dynamic interplay between genetic factors and environmental influences shaping health and behavior. Since its inception, the journal has gained recognition for its commitment to providing open access (since 2015) to groundbreaking research, fostering an inclusive platform for scholars worldwide. With an ISSN of 1880-7046 and an E-ISSN of 1880-7062, Genes and Environment consistently ranks in Q2 in Environmental Science, Q3 in Genetics, and Q2 in Social Psychology according to the 2023 category quartiles, highlighting its significant contributions to these fields. The journal is headquartered in the United Kingdom and has a diverse portfolio of research spanning from 2006 to 2024. It is recognized in Scopus with commendable rankings across various disciplines. By fostering dialogue among researchers, professionals, and students, Genes and Environment serves as a vital resource for understanding complex biological interactions with environmental factors, ultimately aiming to advance knowledge and inform public policy.